179 related articles for article (PubMed ID: 14747238)
1. Lipoprotein(a) is an independent risk factor for peripheral arterial disease in Chinese type 2 diabetic patients in Taiwan.
Tseng CH
Diabetes Care; 2004 Feb; 27(2):517-21. PubMed ID: 14747238
[TBL] [Abstract][Full Text] [Related]
2. Peripheral atherosclerosis and serum lipoprotein(a) in diabetes.
Wollesen F; Dahlén G; Berglund L; Berne C
Diabetes Care; 1999 Jan; 22(1):93-8. PubMed ID: 10333909
[TBL] [Abstract][Full Text] [Related]
3. Influence of lipoprotein(a) on restenosis after femoropopliteal percutaneous transluminal angioplasty in Type 2 diabetic patients.
Maca TH; Ahmadi R; Derfler K; Ehringer H; Gschwandtner ME; Hörl W; Katzenschlager R; Müller-Knespel E; Koppensteiner R; Schneider B; Stümpflen A; Ugurluoglu A; Minar E
Diabet Med; 2002 Apr; 19(4):300-6. PubMed ID: 11943001
[TBL] [Abstract][Full Text] [Related]
4. Sex and ethnic differences in the associations between lipoprotein(a) and peripheral arterial disease in the Multi-Ethnic Study of Atherosclerosis.
Forbang NI; Criqui MH; Allison MA; Ix JH; Steffen BT; Cushman M; Tsai MY
J Vasc Surg; 2016 Feb; 63(2):453-8. PubMed ID: 26518096
[TBL] [Abstract][Full Text] [Related]
5. Serum lipids and lipoprotein(a) concentrations in Chinese NIDDM patients. Relation to metabolic control.
Chang CJ; Kao JT; Wu TJ; Lu FH; Tai TY
Diabetes Care; 1995 Aug; 18(8):1191-4. PubMed ID: 7587858
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and risk factors of peripheral arterial obstructive disease in Taiwanese type 2 diabetic patients.
Tseng CH
Angiology; 2003; 54(3):331-8. PubMed ID: 12785026
[TBL] [Abstract][Full Text] [Related]
7. Influence and interaction of diabetes and lipoprotein (a) serum levels on mortality of patients with peripheral artery disease.
Maca T; Mlekusch W; Doweik L; Budinsky AC; Bischof M; Minar E; Schillinger M
Eur J Clin Invest; 2007 Mar; 37(3):180-6. PubMed ID: 17359485
[TBL] [Abstract][Full Text] [Related]
8. Analysis of traditional and nontraditional risk factors for peripheral arterial disease in elderly type 2 diabetic patients in Taiwan.
Chou CK; Weng SW; Chang HW; Chen CY; Su SC; Liu RT
Diabetes Res Clin Pract; 2008 Sep; 81(3):331-7. PubMed ID: 18639951
[TBL] [Abstract][Full Text] [Related]
9. Plasma lipoprotein(A) levels: a comparison between diabetic and non-diabetic patients with acute ischemic stroke.
Holanda MM; Filizola RG; Costa MJ; Andrade RV; Silva JA
Arq Neuropsiquiatr; 2004 Jun; 62(2A):233-6. PubMed ID: 15235723
[TBL] [Abstract][Full Text] [Related]
10. Lipoprotein(a), inflammation, and peripheral arterial disease in a community-based sample of older men and women (the InCHIANTI study).
Volpato S; Vigna GB; McDermott MM; Cavalieri M; Maraldi C; Lauretani F; Bandinelli S; Zuliani G; Guralnik JM; Fellin R; Ferrucci L
Am J Cardiol; 2010 Jun; 105(12):1825-30. PubMed ID: 20538138
[TBL] [Abstract][Full Text] [Related]
11. Plasma lipoprotein (a) levels in Turkish NIDDM patients with and without vascular diabetic complications.
Erem C; Değer O; Bostan M; Orem A; Sönmez M; Ulusoy S; Telatar M
Acta Cardiol; 1999 Aug; 54(4):203-7. PubMed ID: 10511896
[TBL] [Abstract][Full Text] [Related]
12. Lipoprotein (a) and its relationship to risk factors and severity of atherosclerotic peripheral vascular disease.
Cheng SW; Ting AC; Wong J
Eur J Vasc Endovasc Surg; 1997 Jul; 14(1):17-23. PubMed ID: 9290555
[TBL] [Abstract][Full Text] [Related]
13. Lipoprotein (a) interactions with cholesterol-containing lipids on angiographic coronary collateralization in type 2 diabetic patients with chronic total occlusion.
Shen Y; Chen S; Dai Y; Wang XQ; Zhang RY; Yang ZK; Hu J; Lu L; Ding FH; Shen WF
Cardiovasc Diabetol; 2019 Jun; 18(1):82. PubMed ID: 31234867
[TBL] [Abstract][Full Text] [Related]
14. Prospective study of lipoprotein(a) as a risk factor for atherosclerotic cardiovascular disease in patients with diabetes.
Hiraga T; Kobayashi T; Okubo M; Nakanishi K; Sugimoto T; Ohashi Y; Murase T
Diabetes Care; 1995 Feb; 18(2):241-4. PubMed ID: 7729305
[TBL] [Abstract][Full Text] [Related]
15. Sex difference in the distribution of atherosclerotic risk factors and their association with peripheral arterial disease in Taiwanese type 2 diabetic patients.
Tseng CH
Circ J; 2007 Jul; 71(7):1131-6. PubMed ID: 17587723
[TBL] [Abstract][Full Text] [Related]
16. Serum lipoprotein(a) concentration as a cardiovascular risk factor in Kuwaiti type 2 diabetic patients.
Abdella NA; Mojiminiyi OA; Akanji AO; Al Mohammadi H; Moussa MA
J Diabetes Complications; 2001; 15(5):270-6. PubMed ID: 11522503
[TBL] [Abstract][Full Text] [Related]
17. Diabetic nephropathy and risk factors for peripheral artery disease in Chinese with type 2 diabetes mellitus.
Hsieh MC; Tien KJ; Perng DS; Hsiao JY; Chang SJ; Liang HT; Chen HC; Tu ST
Metabolism; 2009 Apr; 58(4):504-9. PubMed ID: 19303971
[TBL] [Abstract][Full Text] [Related]
18. Lipoprotein profiles, not anthropometric measures, correlate with serum lipoprotein(a) values in children: the Taipei children heart study.
Chu NF; Makowski L; Chang JB; Wang DJ; Liou SH; Shieh SM
Eur J Epidemiol; 2000 Jan; 16(1):5-12. PubMed ID: 10780336
[TBL] [Abstract][Full Text] [Related]
19. Differential influence of LDL cholesterol and triglycerides on lipoprotein(a) concentrations in diabetic patients.
Hernández C; Chacón P; García-Pascual L; Simó R
Diabetes Care; 2001 Feb; 24(2):350-5. PubMed ID: 11213891
[TBL] [Abstract][Full Text] [Related]
20. Lipoprotein (a) and vascular disease in diabetic patients.
James RW; Boemi M; Sirolla C; Amadio L; Fumelli P; Pometta D
Diabetologia; 1995 Jun; 38(6):711-4. PubMed ID: 7672494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
